Viewing nowRovaterol Tablet 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

MFDS item code 201905855 · Approved 2019.08.19 · Insurance code 649605260
Improves dyslipidemia, inhibits the progression of atherosclerosis, and prevents cardiovascular disease
This medication assists in the dietary therapy for patients with hypercholesterolemia and mixed hyperlipidemia who have difficulties controlling cholesterol levels with diet and exercise alone, particularly helping to lower cholesterol levels in children and adolescents with homozygous familial hypercholesterolemia and heterozygous familial hypercholesterolemia. It also supports dietary therapy for patients with primary dysbetalipoproteinemia, effectively lowers total cholesterol and LDL cholesterol levels, and delays the progression of atherosclerosis. It is also used to reduce the risk of stroke, myocardial infarction, and vascular revascularization in middle-aged patients with high cardiovascular disease risk. Overall, this drug is critically important for improving cardiovascular health and controlling blood lipid levels.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Assessment of renal function should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 years ∼ 17 years): The usual dosage range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Children under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients with allergies to any of its components, those with severe liver dysfunction, patients with muscle diseases, those taking certain medications, patients with severe kidney dysfunction, pregnant or breastfeeding women, and patients with specific genetic diseases should not take this medication. Additionally, liver function and muscle condition should be monitored periodically while taking this medication. Special caution is required when consuming alcohol heavily or having a history of liver disease, hypothyroidism, impaired kidney function, a history of muscle issues, elderly patients, and when taking certain medications together. This medication can cause muscle pain, muscle weakness, and rarely serious muscle damage, so if muscle pain, weakness, or cramps occur, the doctor should be notified immediately. Side effects such as abnormal liver function, increased blood sugar, gastrointestinal symptoms, headache, dizziness, skin rashes, etc., may occur, so if these symptoms arise, consult a healthcare professional. This medication has not been established as safe for use in pregnant or breastfeeding women and should not be taken during these periods; women who may become pregnant must use appropriate contraception. Furthermore, since this medication can interact with other drugs, it is important to inform healthcare providers about other medications being taken, especially when combined with certain antiviral drugs, immunosuppressants, antibiotics, and fibrate class medications. In the case of overdose, there is no specific antidote, treatment will depend on symptoms, and monitoring liver function and muscle enzyme levels is necessary. Finally, this medication is known not to significantly affect driving or machine operation, but caution is advised as dizziness may occur.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, ALT increase, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to keep it at room temperature between 1°C and 30°C.
Yellow round film-coated tablet
30 tablets (15 tablets/PTP X 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.